
Sign up to save your podcasts
Or


The FDA approval of TAVR for asymptomatic AS, digital health, subcutaneous vs transvenous ICD, and cryptogenic stroke in young adults are discussed by John Mandrola, MD.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I FDA announces approval for TAVR in pts with asymptomatic AS
II PPG that Can Distinguish source of Tachycardia
III PRAETORIAN -XL trial
IV Stroke in Young People
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
By Medscape4.9
862862 ratings
The FDA approval of TAVR for asymptomatic AS, digital health, subcutaneous vs transvenous ICD, and cryptogenic stroke in young adults are discussed by John Mandrola, MD.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I FDA announces approval for TAVR in pts with asymptomatic AS
II PPG that Can Distinguish source of Tachycardia
III PRAETORIAN -XL trial
IV Stroke in Young People
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]

1,866 Listeners

319 Listeners

545 Listeners

705 Listeners

506 Listeners

163 Listeners

14 Listeners

16 Listeners

3,360 Listeners

135 Listeners

1,152 Listeners

67 Listeners

517 Listeners

373 Listeners

61 Listeners

28 Listeners

8 Listeners

257 Listeners

439 Listeners

268 Listeners